Matuzumab
CAS: 339186-68-4
Ref. TM-T9922
| 1mg | 212.00 € | ||
| 5mg | 541.00 € | ||
| 10mg | 760.00 € | ||
| 25mg | 1,160.00 € | ||
| 50mg | 1,568.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
Matuzumab
Synonyms:
- EMD-72000
- EMD72000
- EMD 72000
- Emd 62000
- Emd 7200
- Emd 72000
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal 425 γ1-chain), disulfide with human-mouse monoclonal 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (humanized MAb 425 γ1-chain), disulfide with humanized MAb 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor)(humanized MAb 425 gamma-1 chain), disulfide with humanized MAb 425 kappa-chain, dimer
- KGaA
- See more synonyms
- Matuzumab [INN]
- Merck KGaA
Description:
Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR that can be used to study non-small cell lung cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
145.9 kDa
Purity:
95%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T9922 Matuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
